Bowel ultrasound score is accurate in assessing response to therapy in patients with Crohn's disease.
Fiche publication
Date publication
novembre 2021
Journal
Alimentary pharmacology & therapeutics
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Allocca M, Craviotto V, Dell'Avalle C, Furfaro F, Zilli A, D'Amico F, Bonovas S, Peyrin-Biroulet L, Fiorino G, Danese S
Lien Pubmed
Résumé
We developed a non-invasive bowel ultrasound score (BUSS) to assess disease activity in Crohn's disease (CD). BUSS >3.52 is an indicator of endoscopic activity (SES-CD>2).
Référence
Aliment Pharmacol Ther. 2021 Nov 15;: